Codexis IncNASDAQ:CDXS
- LAST PRICE4.5600
- TODAY'S CHANGE (%)0.2300 (5.3118%)
- Bid / Lots4.5500/ 6
- Ask / Lots4.5600/ 10
- Open / Previous Close4.3700 / 4.3300
- Day Range
- 52 Week Range
- Volume183,633
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CDXS |
|---|---|---|
| 09:32 ET | 8862 | 4.33 |
| 09:33 ET | 18948 | 4.32 |
| 09:35 ET | 9072 | 4.38 |
| 09:37 ET | 400 | 4.355 |
| 09:39 ET | 100 | 4.3488 |
| 09:42 ET | 400 | 4.38 |
| 09:44 ET | 600 | 4.39 |
| 09:46 ET | 2266 | 4.37 |
| 09:48 ET | 200 | 4.345 |
| 09:50 ET | 678 | 4.3495 |
| 09:51 ET | 300 | 4.35 |
| 09:53 ET | 401 | 4.33 |
| 09:55 ET | 200 | 4.335 |
| 09:57 ET | 500 | 4.33 |
| 10:00 ET | 200 | 4.335 |
| 10:02 ET | 200 | 4.345 |
| 10:04 ET | 100 | 4.36 |
| 10:06 ET | 1600 | 4.335 |
| 10:08 ET | 2988 | 4.355 |
| 10:09 ET | 200 | 4.36 |
| 10:11 ET | 1300 | 4.36 |
| 10:13 ET | 100 | 4.36 |
| 10:15 ET | 400 | 4.38 |
| 10:18 ET | 700 | 4.39 |
| 10:20 ET | 1000 | 4.4 |
| 10:22 ET | 300 | 4.415 |
| 10:24 ET | 1534 | 4.43 |
| 10:26 ET | 3880 | 4.4315 |
| 10:27 ET | 860 | 4.425 |
| 10:29 ET | 1600 | 4.42 |
| 10:31 ET | 100 | 4.4 |
| 10:33 ET | 846 | 4.4 |
| 10:36 ET | 100 | 4.405 |
| 10:38 ET | 1300 | 4.4205 |
| 10:40 ET | 200 | 4.42 |
| 10:42 ET | 1300 | 4.415 |
| 10:44 ET | 700 | 4.405 |
| 10:45 ET | 500 | 4.42 |
| 10:47 ET | 1450 | 4.415 |
| 10:49 ET | 500 | 4.41 |
| 10:51 ET | 1100 | 4.41 |
| 10:54 ET | 100 | 4.42 |
| 10:56 ET | 200 | 4.415 |
| 10:58 ET | 4093 | 4.445 |
| 11:00 ET | 312 | 4.4485 |
| 11:02 ET | 700 | 4.4462 |
| 11:03 ET | 1985 | 4.47 |
| 11:05 ET | 5400 | 4.47 |
| 11:07 ET | 2650 | 4.49 |
| 11:09 ET | 1949 | 4.505 |
| 11:12 ET | 369 | 4.51 |
| 11:14 ET | 400 | 4.515 |
| 11:16 ET | 6992 | 4.52 |
| 11:18 ET | 1336 | 4.53 |
| 11:20 ET | 500 | 4.545 |
| 11:21 ET | 4307 | 4.54 |
| 11:23 ET | 10597 | 4.55 |
| 11:25 ET | 4759 | 4.541 |
| 11:27 ET | 11758 | 4.525 |
| 11:30 ET | 10301 | 4.53 |
| 11:32 ET | 1070 | 4.53 |
| 11:34 ET | 2043 | 4.525 |
| 11:36 ET | 2199 | 4.51 |
| 11:38 ET | 810 | 4.52 |
| 11:39 ET | 3300 | 4.545 |
| 11:41 ET | 2861 | 4.535 |
| 11:43 ET | 300 | 4.54 |
| 11:45 ET | 987 | 4.545 |
| 11:48 ET | 5900 | 4.55 |
| 11:50 ET | 2300 | 4.555 |
| 11:52 ET | 500 | 4.56 |
Today
Nov 19, 2024
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference, from 4:05PM ET on Tuesday Nov 19, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 15, 2024
DJ Codexis Price Target Maintained With a $11.00/Share by Cantor Fitzgerald, from 9:49AM ET on Friday Nov 15, 2024 by Dow Jones
9:49AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics, from 4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
Codexis Announces Appointment of Raymond De Vr , PhD, to Board of Directors, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Codexis Inc | 352.4M | -5.2x | --- |
Poseida Therapeutics Inc | 264.1M | -4.5x | --- |
AVITA Medical Inc | 337.4M | -6.1x | --- |
Contineum Therapeutics Inc | 369.7M | -10.1x | --- |
Personalis Inc | 238.8M | -2.1x | --- |
SAGE Therapeutics Inc | 296.7M | -0.9x | --- |
Company Information
Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Contact Information
- Headquarters
- 200 Penobscot DrREDWOOD CITY, CA, United States 94063-4718
- Phone
- 650-421-8100
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Stephen Dilly
- Chief Financial Officer
- Georgia Erbez
- Chief Operating Officer
- Kevin Norrett
- Senior Vice President - Commercial Operations
- Britton Jimenez
- Senior Vice President - Intellectual Property
- John Schiffhauer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $352.4M |
|---|---|
Revenue (TTM) | $64.4M |
Shares Outstanding | 81.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.11 |
EPS | $-0.88 |
Book Value | $1.24 |
P/E Ratio | -5.2x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -78.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
